Pharmacokinetics, Safety, and Tolerability of Phentermine in Healthy Participants Receiving Taranabant, a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics, Safety, and Tolerability of Phentermine in Healthy Participants Receiving Taranabant, a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist

Published:2009-10 Issue:10 Volume:49 Page:1228-1238
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Addy Carol,Jumes Patricia,Rosko Kimberly,Li Susie,Li Hankun,Maes Andrea,Johnson-Levonas Amy O.,Chodakewitz Jeffrey,Stoch S. Aubrey,Wagner John A.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1177/0091270009341651/fullpdf

Reference26 articles.

1. Pharmacological treatment of the overweight patient;Bray;Pharmacol Rev,2007

2. Dexfenfluramine, fenfluramine, and phentermine for the treatment of morbid obesity;Torretta;J Am Acad Nurse Pract,1997

3. Appetite suppressants and valvular heart disease;Seghatol;Curr Opin Cardiol,2002

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy of Obesity and Metabolic Syndrome;Metabolic Syndrome;2023

2. Pharmacotherapy of Obesity and Metabolic Syndrome;Metabolic Syndrome;2023

3. The Science of Obesity Management: An Endocrine Society Scientific Statement;Endocrine Reviews;2018-03-06

4. Association of subarachnoid hemorrhage and phentermine usage: Coincidence, not causation;Journal of the American Pharmacists Association;2015-03

5. The Doctor’s Tool Kit: Pharmacotherapy for the Patient with Obesity;The Clinician’s Guide to the Treatment of Obesity;2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP